Biotech Distilled
Substack ↗
Subscribe
Subscribe
Substack ↗
About
Research
Areas
Modalities
Phases
Targets
Track record
Movers
The Lead Compound
Home
›
Targets
› α4β7 integrin
α4β7 integrin
(1 companies · 2 programs)
Companies with an active program directed at α4β7 integrin.
Spyre Therapeutics, Inc.
SYRE
SPY001
— Ulcerative Colitis
Phase 2
SPY001
— Crohn's Disease
Phase 2